191 related articles for article (PubMed ID: 17410467)
1. Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers.
Kim HK; Kim JI; Kim JK; Han JY; Park SH; Choi KY; Chung IS
Dig Dis Sci; 2007 Aug; 52(8):1776-82. PubMed ID: 17410467
[TBL] [Abstract][Full Text] [Related]
2. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.
Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E
Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232
[TBL] [Abstract][Full Text] [Related]
3. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
Fujimori S; Takahashi Y; Gudis K; Seo T; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel.
Tozawa K; Oshima T; Okugawa T; Ogawa T; Ohda Y; Tomita T; Hida N; Fukui H; Hori K; Watari J; Nakamura S; Miwa H
Dig Dis Sci; 2014 Aug; 59(8):1885-90. PubMed ID: 24659236
[TBL] [Abstract][Full Text] [Related]
5. Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.
Gagliano-Jucá T; Moreno RA; Zaminelli T; Napolitano M; Magalhães AF; Carvalhaes A; Trevisan MS; Wallace JL; De Nucci G
BMC Gastroenterol; 2016 Jun; 16(1):58. PubMed ID: 27259970
[TBL] [Abstract][Full Text] [Related]
6. Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
Kim JH; Park SH; Cho CS; Lee ST; Yoo WH; Kim SK; Kang YM; Rew JS; Park YW; Lee SK; Lee YC; Park W; Lee DH
Gut Liver; 2014 Jul; 8(4):371-9. PubMed ID: 25071901
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury.
Kurokawa S; Katsuki S; Fujita T; Saitoh Y; Ohta H; Nishikawa K; Sato Y; Sato Y; Ohira K; Yamada M; Kato M
J Gastroenterol; 2014 Feb; 49(2):239-44. PubMed ID: 23595613
[TBL] [Abstract][Full Text] [Related]
8. Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy).
Yamao J; Kikuchi E; Matsumoto M; Nakayama M; Ann T; Kojima H; Mitoro A; Yoshida M; Yoshikawa M; Yajima H; Miyauchi Y; Ono H; Akiyama K; Sakurai G; Kinoshita Y; Haruma K; Takakura Y; Fukui H
J Gastroenterol; 2006 Dec; 41(12):1178-85. PubMed ID: 17287897
[TBL] [Abstract][Full Text] [Related]
9. Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide.
Haruma K; Ito M
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():153-9. PubMed ID: 12925154
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Niwa Y; Nakamura M; Ohmiya N; Maeda O; Ando T; Itoh A; Hirooka Y; Goto H
J Gastroenterol; 2008; 43(4):270-6. PubMed ID: 18458842
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.
Ishihara T; Tanaka K; Tashiro S; Yoshida K; Mizushima T
Biochem Pharmacol; 2010 Jun; 79(11):1622-33. PubMed ID: 20132796
[TBL] [Abstract][Full Text] [Related]
12. Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat.
Kim CD; Hong KW
J Pharmacol Exp Ther; 1995 Oct; 275(1):340-4. PubMed ID: 7562569
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of Gastric Mucosal Injury Model Animals of Rebamipide Formulation--Study of Therapeutic Equivalence].
Abe N; Funato H; Hirata A; Nakai M; Iizuka M; Shiraishi H; Jobu K; Yagi Y; Kadota A; Ogi K; Yokota J; Miyamura M
Yakugaku Zasshi; 2016; 136(4):677-84. PubMed ID: 27040349
[TBL] [Abstract][Full Text] [Related]
14. Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression.
Hiratsuka T; Futagami S; Shindo T; Hamamoto T; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Shinoki K; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S84-9. PubMed ID: 16184426
[TBL] [Abstract][Full Text] [Related]
15. Aspirin-induced small bowel injuries and the preventive effect of rebamipide.
Mizukami K; Murakami K; Abe T; Inoue K; Uchida M; Okimoto T; Kodama M; Fujioka T
World J Gastroenterol; 2011 Dec; 17(46):5117-22. PubMed ID: 22171147
[TBL] [Abstract][Full Text] [Related]
16. Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.
Wood RC; Wyatt JE; Bullins KW; Hanley AV; Hanley GA; Denham JW; Panus PC; Harirforoosh S
Eur J Pharmacol; 2013 Nov; 720(1-3):138-46. PubMed ID: 24365796
[TBL] [Abstract][Full Text] [Related]
17. Effects of rebamipide, a novel anti-ulcer agent, on gastric mucosal injury induced by platelet-activating factor in rats.
Kokura S; Yoshikawa T; Naito Y; Ichikawa H; Takano H; Takahashi S; Tomii T; Yoshida N; Kondo M
Dig Dis Sci; 1997 Dec; 42(12):2566-71. PubMed ID: 9440637
[TBL] [Abstract][Full Text] [Related]
18. [Protective effect of rebamipide (OPC-12759) on the gastric mucosa in rats and humans].
Kawano S; Sato N; Kamada T; Yamasaki K; Imaizumi T; Komemushi S
Nihon Yakurigaku Zasshi; 1991 Jun; 97(6):371-80. PubMed ID: 1651893
[TBL] [Abstract][Full Text] [Related]
19. Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.
Thong-Ngam D; Chayanupatkul M; Klaikeaw N; Rerknimitr R; Mahachai V
J Med Assoc Thai; 2009 Sep; 92(9):1207-12. PubMed ID: 19772181
[TBL] [Abstract][Full Text] [Related]
20. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
